Literature DB >> 1470707

High dose inhaled steroid therapy and the cortisol stress response to acute severe asthma.

P H Brown1, G Blundell, A P Greening, G K Crompton.   

Abstract

Systemic absorption of inhaled corticosteroids taken in high doses (> or = 1500 micrograms beclomethasone dipropionate or budesonide daily), may cause suppression of the hypothalamo-pituitary-adrenal axis. Patients taking long-term high dose inhaled steroid therapy might therefore be at risk of adrenal crisis at times of stress. Plasma cortisol levels were measured in 24 adults with severe acute asthma who had not received treatment with systemic corticosteroids prior to hospital attendance. Seven were not taking inhaled steroids, four were taking 600-1200 micrograms and 13 were taking 1500-2400 micrograms beclomethasone dipropionate or budesonide daily. Plasma cortisol levels in these 13 (median 594 nmol l-1, interquartile range 399-620 nmol l-1) were similar to levels in those taking lower dose/no inhaled steroids (median 512 nmol l-1, interquartile range 287-1050 nmol l-1): there was no relationship between inhaled steroid dose and cortisol level. Nine of the 24 patients failed to achieve plasma cortisol values > 500 nmol l-1 (the normal response to an insulin stress test). When compared with the remaining 15, they had less severe asthma as indicated by higher arterial oxygen tension (P < 0.01) and peak expiratory flow (P < 0.03). Patients taking long-term high dose inhaled corticosteroids appear to be able to mount an appropriate adrenocortical response to the stress of severe acute asthma.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1470707     DOI: 10.1016/s0954-6111(96)80009-6

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  6 in total

Review 1.  Clinical management of asthma in the 1990s. Current therapy and new directions.

Authors:  P Jain; J A Golish
Journal:  Drugs       Date:  1996       Impact factor: 9.546

Review 2.  Dose-response of inhaled drugs in asthma. An update.

Authors:  D J Clark; B J Lipworth
Journal:  Clin Pharmacokinet       Date:  1997-01       Impact factor: 6.447

3.  Systemic effects of inhaled corticosteroids.

Authors:  J P Monson
Journal:  Thorax       Date:  1993-10       Impact factor: 9.139

Review 4.  Inhaled corticosteroid therapy in children: an assessment of the potential for side effects.

Authors:  G Russell
Journal:  Thorax       Date:  1994-12       Impact factor: 9.139

5.  Systemic effects of high dose inhaled steroids: comparison of beclomethasone dipropionate and budesonide in healthy subjects.

Authors:  P H Brown; S P Matusiewicz; C Shearing; L Tibi; A P Greening; G K Crompton
Journal:  Thorax       Date:  1993-10       Impact factor: 9.139

6.  Inhaled Corticosteroids Adverse Events In Asthmatic Children: A Review.

Authors:  Saad Alotaibi; Farhan Alshammari
Journal:  Internet J Pediatr Neonatol       Date:  2006
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.